CLINICAL AND ECONOMICAL EFFICIENCY OF CAMPHORATED OIL IN INCONTINENCE ASSOCIATED DERMATITIS
DOI:
https://doi.org/10.11603/1681-2786.2018.4.9753Keywords:
incontinence associated dermatitis, camphorated oilAbstract
Purpose: to investigate the clinical and economic efficiency of camphorated oil in the treatment of incontinence associated dermatitis.
Materials and methods. A prospective observational study included 134 adult patients with incontinence associated dermatitis. In the study group (n = 104) camphorated oil was used for cleansing and protecting the skin. In the control group (n = 30), wet wipes 3 in 1 or a combination of cleansing foam and protective cream were used. The average age of patients was 77 ± 11 (range 36 - 92) years, of which 83 (61.9%) were women. All patients were urinary incontinent while 48 residents (35.8 %) had double urinary and faecal incontinence. Mycological swab specimens were cultured directly on Sabouraud’s medium for yeasts and incubated at 37° Celsius for 48-72 hours to identify Candida spp. Statistical data were analysed using the Microsoft Excel® 2016 and MedCalc® software. The change was considered reliable at a level of significance not less than 0.05 (p <0,05). The comparison between the groups was performed using regression analysis to determine the odds ratio at 95% confidence interval.
Results. The significant decrease was revealed in the number of patients with GLOBIAD category 2B from 30 (28.8%) to 16 (15.4%) patients (χ2 = 22.1; p <0.001) and an significant increase in the size of category 1A from 29 ( 27,9%) to 52 (50,0%) patients (χ2 = 12,07; p <0,001) after 1 month period of the study drug application. Fungal rash was observed at the initial visit in 53 (51.0%) of the studied patients, which, after the course of treatment, decreased significantly and was determined in 33 (31.7%) subjects (χ2 = 16.4; p <0.001). Fungal rash was confirmed mycologically in 30 (28.8%) subjects, and after treatment only in 8 (7.8%) patients (χ2 = 20.05; p <0.001). An economic analysis showed that one procedure of skin care by camphorated oil cost UAH 0.65, whereas, in the control group 1.65 UAH was spent for routine treatment.
Conclusions. Topical use of camphorated oil decreased the severity of the disease, reduced fungal appearing rash and Candida spp. colonisation, and was cost saving comparatively to routine skin care products in incontinence associated dermatitis.
References
Beeckman, D., Campbell, J., & Chimentгo, D. (2015). Proceedings of the Global IAD Expert Panel. Incontinence associated dermatitis: moving prevention forward. Wounds International. Retrieved from: www.woundsinternational.com.
Beeckman, D., Van Damme, N., Schoonhoven, L., Van Lancker, A., Kottner, J., Beele, H., et al. (2016). Interventions for preventing and treating incontinence-associated dermatitis in adults. Cochrane Database of Systematic Reviews, 11, CD011627.
Campbell, J., Coyer, F., Mudge, A., Robertson, I., & Osborne, S. (2017). Candida albicans colonisation, continence status and incontinence-associated dermatitis in the acute care setting: a pilot study. Int Wound J., 14, 488-495.
Kotaka, T., Kimura, S., Kashiwayanagi, M., & Iwamoto, J. (2014). Camphor induces cold and warm sensations with increases in skin and muscle blood flow in human. Biol. Pharm. Bull., 37, 1913-1918.
Pather, P., Hines, S., Kynoch, K., & Coyer, F. (2017). Effectiveness of topical skin products in the treatment and prevention of incontinence-associated dermatitis: a systematic review. JBI Database System Rev. Implement Rep., 15, 1473-1496.
Van den Bussche, K., De Meyer, D., Van Damme, N., Kottner, J., & Beeckman, D. (2017). CONSIDER - Core Outcome Set in IAD Research: study protocol for establishing a core set of outcomes and measurements in incontinence-associated dermatitis research. J. Adv. Nurs., 73, 2473-2483.
Vaughn, A.R., Clark, A.K., Sivamani, R.K., & Shi, V.Y. (2018). Natural oils for skin-barrier repair: ancient compounds now backed by modern science. Am. J. Clin. Dermatol., 19, 103-117.
Woo, K. (2014). Health economic benefits of cyanoacrylate skin protectants in the management of superficial skin lesions. International Wound Journal, 11, 431-437.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish in this journal agree to the following terms:
1. The authors reserve the right to authorship of the work and pass the journal right of first publication of this work is licensed under a Creative Commons Attribution License, which allows others to freely distribute the work published with reference to the authors of the original work and the first publication of this magazine.
2. Authors are entitled to enter into a separate agreement on additional non-exclusive distribution of work in the form in which it was published in the magazine (eg work place in the electronic repository institution or publish monographs in part), provided that the reference to the first publication of this magazine.
3. Policy magazine allows and encourages authors placement on the Internet (eg, in storage facilities or on personal websites) manuscript of how to submit the manuscript to the editor and during his editorial processing, since it contributes to productive scientific discussion and positive impact on the efficiency and dynamics of citing published work (see. The Effect of Open Access).